Unveiling the Hidden Chemistry of CBD Metabolism

This groundbreaking study delves into the metabolic process of cannabidiol (CBD), uncovering important insights about how the body breaks down and processes this popular cannabinoid. Researchers investigated the formation of a specific metabolite called 7-carboxy-cannabidiol (7-COOH-CBD), focusing on its transformation into acyl glucuronide and phenolic glucuronide in human biological systems.

The research revealed complex metabolic pathways involving specific enzymes (UGT1A1, UGT1A3, and UGT1A9) responsible for metabolizing 7-COOH-CBD. Interestingly, the study found that the metabolite can undergo significant chemical changes when interacting with different proteins, such as human serum albumin and liver fatty acid binding protein (FABP1). These interactions could potentially impact the metabolic efficiency and toxicity of CBD in the human body.

Of particular concern, the findings suggest that the 7-COOH-CBD-acyl-glucuronide metabolite may play a role in CBD-related liver toxicity. This highlights the importance of understanding the complex biochemical processes that occur when cannabinoids are metabolized, and underscores the need for further research into the potential long-term effects of CBD consumption.